Published in Arch Ophthalmol on May 01, 2002
Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Arch Clin Exp Ophthalmol (2010) 0.91
Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye (Lond) (2011) 0.90
Presumed endophthalmitis following Boston keratoprosthesis treated with 25 gauge vitrectomy: a report of three cases. Graefes Arch Clin Exp Ophthalmol (2009) 0.87
[Results with the Boston keratoprosthesis]. Ophthalmologe (2012) 0.82
Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients. Br J Ophthalmol (2006) 0.80
Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure. Br J Ophthalmol (2004) 0.80
Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review. Saudi J Ophthalmol (2015) 0.78
Keratoprostheses for corneal blindness: a review of contemporary devices. Clin Ophthalmol (2015) 0.77
Pars plana vitrectomy through the Boston Keratoprosthesis type 1. Eye (Lond) (2013) 0.76
Visually evoked potentials in a patient with a fyodorov-zuev keratoprosthesis. Case Rep Ophthalmol (2015) 0.75
Streptococcus agalactiae Endophthalmitis in Boston Keratoprosthesis in a Patient with Steven-Johnson Syndrome. Middle East Afr J Ophthalmol (2016) 0.75
Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes. Digit J Ophthalmol (2015) 0.75
Posterior Pole Retinal Detachment Due to a Macular Hole in a Patient with a Boston Keratoprosthesis. Am J Ophthalmol Case Rep (2016) 0.75
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
A comparison of same setting versus delayed vitrectomy in the management of retained lens fragments after cataract surgery. Retina (2014) 2.00
Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina (2012) 1.95
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology (2006) 1.80
Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol (2012) 1.71
Choroidal neovascularization after epiretinal membrane removal. Arch Ophthalmol (2006) 1.70
The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology (2002) 1.70
Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin (2007) 1.61
Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol (2010) 1.60
Wide-angle fundus imaging through the Boston keratoprosthesis. Retina (2013) 1.40
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology (2005) 1.34
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol (2006) 1.32
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol (2005) 1.17
Retinal microvascular surgery: a feasibility study. Invest Ophthalmol Vis Sci (2004) 1.17
Pseudophakic cystoid macular edema. Semin Ophthalmol (2003) 1.16
Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea (2007) 1.14
Cataract surgery as a risk factor for retinal detachment in very highly myopic eyes. Ophthalmology (2003) 1.13
Optical functional properties of the Boston Keratoprosthesis. Invest Ophthalmol Vis Sci (2009) 1.13
Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J (2002) 1.12
Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea (2009) 1.12
Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma. Arch Ophthalmol (2003) 1.10
The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea (2011) 1.09
A drug-eluting contact lens. Invest Ophthalmol Vis Sci (2009) 1.08
Fungal colonization and infection in Boston keratoprosthesis. Cornea (2007) 1.07
Alkali burn to the eye: protection using TNF-α inhibition. Cornea (2014) 1.07
The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin (2008) 1.07
The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol (2008) 1.04
The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol (2008) 1.03
Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol (2007) 1.03
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology (2003) 1.01
Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina (2006) 1.00
Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol (2002) 1.00
Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment. Clin Ophthalmol (2012) 0.96
The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea (2009) 0.95
Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea (2014) 0.95
Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin (2005) 0.94
Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis. Arch Ophthalmol (2011) 0.94
Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol (2011) 0.92
Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma (2009) 0.91
Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina (2002) 0.89
Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol (2014) 0.89
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol (2010) 0.88
The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol (2007) 0.87
Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Contact lenses for drug delivery. Semin Ophthalmol (2009) 0.87
Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol (2009) 0.87
A review of corneal melting after Boston Keratoprosthesis. Semin Ophthalmol (2014) 0.87
Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography. Clin Ophthalmol (2012) 0.86
In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci (2013) 0.86
Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology (2008) 0.86
Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab. Hum Gene Ther (2011) 0.86
Ultra-widefield imaging for the management of pediatric retinal diseases. J Pediatr Ophthalmol Strabismus (2013) 0.86
Hydroxyapatite for keratoprosthesis biointegration. Invest Ophthalmol Vis Sci (2011) 0.85
Intraocular pressure measurement by radio wave telemetry. Invest Ophthalmol Vis Sci (2011) 0.85
Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. Biomaterials (2011) 0.84
Biologic keratoprosthesis materials. Int Ophthalmol Clin (2009) 0.84
Isolated foveal hypoplasia without nystagmus. Int Ophthalmol (2014) 0.83
Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol (2012) 0.83
Perfluorocarbon liquid utilization in primary vitrectomy repair of retinal detachment with multiple breaks. Retina (2003) 0.83
Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases. Cornea (2015) 0.83
Surgical and other treatments of diabetic macular edema: an update. Int Ophthalmol Clin (2004) 0.82
Wound anatomy after type 1 Boston KPro using oversized back plates. Cornea (2013) 0.82
Mechanisms of corneal ulceration. Ophthalmol Clin North Am (2002) 0.82
Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2004) 0.82
Trans-orbital foreign body with intracranial extension. J Trauma (2006) 0.81
Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice. Ophthalmol Clin North Am (2006) 0.81
Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin (2004) 0.81
Sudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea (2005) 0.80
Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis. Cornea (2011) 0.80
Chemical burns to the eye: paradigm shifts in treatment. Cornea (2011) 0.79
Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function. PLoS One (2013) 0.79
Very low risk of light-induced retinal damage during Boston keratoprosthesis surgery: a rabbit study. Cornea (2014) 0.79
Three-dimensional reconstruction and analysis of vitreomacular traction: quantification of cyst volume and vitreoretinal interface area. Arch Ophthalmol (2011) 0.78
Controversies in proliferative vitreoretinopathy tamponade and pharmacologic adjuvants. Int Ophthalmol Clin (2005) 0.78
Keratoprosthesis in congenital hereditary endothelial dystrophy after multiple failed grafts. Digit J Ophthalmol (2011) 0.78
UV cross-linking of donor corneas confers resistance to keratolysis. Cornea (2014) 0.77
Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration. Surv Ophthalmol (2007) 0.77
Stability and in vitro toxicity of an infliximab eye drop formulation. Int J Pharm Compd (2015) 0.77
Effect of Penetrating Keratoplasty and Keratoprosthesis Implantation on the Posterior Segment of the Eye. Invest Ophthalmol Vis Sci (2016) 0.77
The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea (2013) 0.77
Corneal blindness from end-stage Sjögren's syndrome and graft-versus-host disease. Adv Exp Med Biol (2002) 0.77
Blindness in an American boy caused by unrecognized vitamin A deficiency. Arch Ophthalmol (2004) 0.77
Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm (2010) 0.76
Elevated erythropoietin and vascular endothelial growth factor levels in an adolescent with retinal neovascularization from a chronic rhegmatogenous retinal detachment. Retin Cases Brief Rep (2008) 0.76
Dystrophic calcification of the fibrous capsule around a hydrogel explant 13 years after scleral buckling surgery: capsular calcification of a hydrogel explant. Retina (2005) 0.76
Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema. Clin Ophthalmol (2012) 0.76
Corneal oedema in ocular hypotony. Exp Eye Res (2004) 0.76
Controversies in intravitreal triamcinolone acetonide use. Int Ophthalmol Clin (2005) 0.76
Volumetric three-dimensional reconstruction and segmentation of spectral-domain OCT. Ophthalmic Surg Lasers Imaging (2011) 0.75
New methods for retinal examination in eyes with a Boston keratoprosthesis. Retina (2013) 0.75
Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumab. J Ophthalmic Inflamm Infect (2011) 0.75
Ultra-widefield fluorescein angiography of white without pressure. Clin Ophthalmol (2013) 0.75
Fungal Infections After Boston Type 1 Keratoprosthesis Implantation: Literature Review and In Vitro Antifungal Activity of Hypochlorous Acid. Cornea (2015) 0.75
Tear Matrix Metalloproteinases and Myeloperoxidase Levels in Patients With Boston Keratoprosthesis Type I. Cornea (2016) 0.75
Oral acetazolamide after Boston keratoprosthesis in Stevens-Johnson syndrome. BMC Res Notes (2012) 0.75
Reply: To PMID 24853687. Retina (2014) 0.75